RecruitingNCT01644903
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
Sponsor
Northwestern University
Enrollment
1,000 participants
Start Date
Apr 1, 2010
Study Type
OBSERVATIONAL
Conditions
Summary
This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function properly. Early detection of these conditions could assist with successful treatment and possibly lead to less repeat organ transplants.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Male and female recipients of all races, ≥18 years of age.
- Patients undergoing primary or subsequent living or deceased donor liver transplantation.
- Subject and/or guardian must be able to provide informed consent.
- Subject and/or guardian must be able to comply with the study protocol.
Exclusion Criteria1
- \. Inability or unwillingness of a participant and/or guardian to provide informed consent.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01644903
Related Trials
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
NCT06926660153 locations
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
NCT07107945102 locations
An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea
NCT072325371 location
Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care
NCT071694221 location
A Prospecitve Multicenter, Observational Registry Study
NCT074815261 location